Found: 16
Select item for more details and to access through your institution.
Identification of an Optimal COVID-19 Booster Allocation Strategy to Minimize Hospital Bed-Days with a Fixed Healthcare Budget.
- Published in:
- Vaccines, 2023, v. 11, n. 2, p. 377, doi. 10.3390/vaccines11020377
- By:
- Publication type:
- Article
The cost‐effectiveness of dapagliflozin in treating high‐risk patients with type 2 diabetes mellitus: An economic evaluation using data from the DECLARE‐TIMI 58 trial.
- Published in:
- Diabetes, Obesity & Metabolism, 2021, v. 23, n. 4, p. 1020, doi. 10.1111/dom.14308
- By:
- Publication type:
- Article
Cost‐effectiveness of dapagliflozin as an adjunct to insulin for the treatment of type 1 diabetes mellitus in the United Kingdom.
- Published in:
- Diabetes, Obesity & Metabolism, 2020, v. 22, n. 7, p. 1047, doi. 10.1111/dom.13992
- By:
- Publication type:
- Article
An alternative approach to modelling HbA1c trajectories in patients with type 2 diabetes mellitus.
- Published in:
- Diabetes, Obesity & Metabolism, 2017, v. 19, n. 5, p. 628, doi. 10.1111/dom.12865
- By:
- Publication type:
- Article
Estimating Cost-Effectiveness in Type 2 Diabetes: The Impact of Treatment Guidelines and Therapy Duration.
- Published in:
- 2015
- By:
- Publication type:
- Journal Article
Cost‐effectiveness of dapagliflozin as a treatment for heart failure with reduced ejection fraction: a multinational health‐economic analysis of DAPA‐HF.
- Published in:
- European Journal of Heart Failure, 2020, v. 22, n. 11, p. 2147, doi. 10.1002/ejhf.1978
- By:
- Publication type:
- Article
A Systematic Review of Cost-Effectiveness Models in Type 1 Diabetes Mellitus.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Assessing the relationship between computational speed and precision: a case study comparing an interpreted versus compiled programming language using a stochastic simulation model in diabetes care.
- Published in:
- 2010
- By:
- Publication type:
- journal article
Assessing the Relationship between Computational Speed and Precision.
- Published in:
- PharmacoEconomics, 2010, v. 28, n. 8, p. 665, doi. 10.2165/11535350-000000000-00000
- By:
- Publication type:
- Article
Cost Effectiveness of Adding Dapagliflozin to Insulin for the Treatment of Type 2 Diabetes Mellitus in the Netherlands.
- Published in:
- Clinical Drug Investigation, 2014, v. 34, n. 2, p. 135, doi. 10.1007/s40261-013-0155-0
- By:
- Publication type:
- Article
Cost Effectiveness of Saxagliptin and Metformin versus Sulfonylurea and Metformin in the Treatment of Type 2 Diabetes Mellitus in Germany.
- Published in:
- Clinical Drug Investigation, 2012, v. 32, n. 3, p. 189, doi. 10.2165/11597060-000000000-00000
- By:
- Publication type:
- Article
The Humanistic Burden of Type 1 Diabetes Mellitus in Europe: Examining Health Outcomes and the Role of Complications.
- Published in:
- PLoS ONE, 2016, v. 11, n. 11, p. 1, doi. 10.1371/journal.pone.0164977
- By:
- Publication type:
- Article
The Health Economic Value of Changes in Glycaemic Control, Weight and Rates of Hypoglycaemia in Type 1 Diabetes Mellitus.
- Published in:
- PLoS ONE, 2016, v. 11, n. 9, p. 1, doi. 10.1371/journal.pone.0162441
- By:
- Publication type:
- Article
Modeling Chronic Kidney Disease in Type 2 Diabetes Mellitus: A Systematic Literature Review of Models, Data Sources, and Derivation Cohorts.
- Published in:
- Diabetes Therapy, 2022, v. 13, n. 4, p. 651, doi. 10.1007/s13300-022-01208-0
- By:
- Publication type:
- Article
Assessment of Unmet Clinical Need in Type 2 Diabetic Patients on Conventional Therapy in the UK.
- Published in:
- Diabetes Therapy, 2014, v. 5, n. 2, p. 567, doi. 10.1007/s13300-014-0079-6
- By:
- Publication type:
- Article
Validation of the UKPDS 82 risk equations within the Cardiff Diabetes Model.
- Published in:
- Cost Effectiveness & Resource Allocation, 2015, v. 13, n. 1, p. 1, doi. 10.1186/s12962-015-0038-8
- By:
- Publication type:
- Article